Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 2.

D'Ambrosio, Lorenzo, Touati, Nathan, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Grignani, Giovanni, Flippot, Ronan, Czarnecka, Anna M., Piperno-Neumann, Sophie, Martin-Broto, Javier ORCID: 0000-0001-7350-6916, Sanfilippo, Roberta, Katz, Daniela, Duffaud, Florence, Vincenzi, Bruno, Stark, Daniel P., Mazzeo, Filomena, Tuchscherer, Armin, Chevreau, Christine, Sherriff, Jenny, Estival, Anna, Litiere, Saskia, Sents, Ward, Ray-Coquard, Isabelle, Tolomeo, Francesco, Le Cesne, Axel, Rutkowski, Piotr, Stacchiotti, Silvia, Kasper, Bernd, Gelderblom, Hans and Gronchi, Alessandro (2020). Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Cancer, 126 (11). S. 2637 - 2648. HOBOKEN: WILEY. ISSN 1097-0142

Rusakiewicz, Sylvie, Perier, Aurelie, Semeraro, Michaela, Pitt, Jonathan M., von Strandmann, Elke Pogge, Reiners, Katrin S., Aspeslagh, Sandrine, Piperoglou, Christelle, Vely, Frederic, Ivagnes, Alexandre, Jegou, Sarah, Halama, Niels, Chaigneau, Loic, Validire, Pierre, Christidis, Christos, Perniceni, Thierry, Landi, Bruno, Berger, Anne, Isambert, Nicolas, Domont, Julien, Bonvalot, Sylvie, Terrier, Philippe, Adam, Julien, Coindre, Jean-Michel, Emile, Jean-Francois, Poirier-Colame, Vichnou, Chaba, Kariman, Rocha, Benedita, Caignard, Anne ORCID: 0000-0001-9923-6045, Toubert, Antoine, Enot, David, Koch, Joachim, Marabelle, Aurelien, Lambert, Marion, Caillat-Zucman, Sophie ORCID: 0000-0002-4535-3550, Leyvraz, Serge, Auclair, Christian, Vivier, Eric ORCID: 0000-0001-7022-8287, Eggermont, Alexander, Borg, Christophe, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Le Cesne, Axel, Mir, Olivier ORCID: 0000-0002-6761-4002 and Zitvogel, Laurence (2017). NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients. OncoImmunology, 6 (1). PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 2162-402X

This list was generated on Tue Nov 26 04:11:19 2024 CET.